DK1370264T3 - Nikotinreceptor-agonister til behndling af lungeinflammationssygdomme - Google Patents

Nikotinreceptor-agonister til behndling af lungeinflammationssygdomme

Info

Publication number
DK1370264T3
DK1370264T3 DK02717896T DK02717896T DK1370264T3 DK 1370264 T3 DK1370264 T3 DK 1370264T3 DK 02717896 T DK02717896 T DK 02717896T DK 02717896 T DK02717896 T DK 02717896T DK 1370264 T3 DK1370264 T3 DK 1370264T3
Authority
DK
Denmark
Prior art keywords
agonists
pulmonary
receptor agonists
diseases
nicotine receptor
Prior art date
Application number
DK02717896T
Other languages
Danish (da)
English (en)
Inventor
Yvon Cormier
Evelyne Israel-Assayag
Marie-Renee Blanchet
Original Assignee
Univ Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Laval filed Critical Univ Laval
Application granted granted Critical
Publication of DK1370264T3 publication Critical patent/DK1370264T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02717896T 2001-03-23 2002-03-25 Nikotinreceptor-agonister til behndling af lungeinflammationssygdomme DK1370264T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002341952A CA2341952A1 (en) 2001-03-23 2001-03-23 Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
PCT/CA2002/000412 WO2002076434A2 (en) 2001-03-23 2002-03-25 Nicotinic receptor agonists for the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
DK1370264T3 true DK1370264T3 (da) 2008-03-17

Family

ID=4168679

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02717896T DK1370264T3 (da) 2001-03-23 2002-03-25 Nikotinreceptor-agonister til behndling af lungeinflammationssygdomme

Country Status (18)

Country Link
US (3) US7601720B2 (pl)
EP (1) EP1370264B1 (pl)
JP (1) JP4377586B2 (pl)
CN (1) CN100528159C (pl)
AT (1) ATE378051T1 (pl)
AU (1) AU2002249023B2 (pl)
BR (1) BR0208305A (pl)
CA (1) CA2341952A1 (pl)
DE (1) DE60223508T2 (pl)
DK (1) DK1370264T3 (pl)
ES (1) ES2295331T3 (pl)
IL (1) IL157757A0 (pl)
MX (1) MXPA03008423A (pl)
NO (1) NO331674B1 (pl)
NZ (1) NZ528042A (pl)
PL (1) PL207880B1 (pl)
RU (1) RU2299731C2 (pl)
WO (1) WO2002076434A2 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
US20050130990A1 (en) * 2001-03-23 2005-06-16 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
CA2341952A1 (en) 2001-03-23 2002-09-23 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
US7045534B2 (en) * 2002-02-12 2006-05-16 The Board Of Trustees Of The Leland Stanford Junior University Methods of reducing angiogenesis
US8557804B2 (en) 2002-03-25 2013-10-15 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
US8039459B2 (en) 2004-07-15 2011-10-18 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
US20040010018A1 (en) * 2002-05-15 2004-01-15 Rueter Lynne E. Treatment of neuropathic pain
US7238715B2 (en) 2002-12-06 2007-07-03 The Feinstein Institute For Medical Research Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
PL364348A1 (pl) 2004-01-12 2005-07-25 PHARMENA Sp.z o.o. Zastosowanie czwartorzędowych soli pirydyniowych jako środka naczynioprotekcyjnego
ES2445751T3 (es) * 2004-07-15 2014-03-05 UNIVERSITé LAVAL Agonistas de receptor nicotínico para el tratamiento de enfermedades inflamatorias
WO2006086068A1 (en) 2004-12-07 2006-08-17 The Regents Of The University Of California Labeled alpha-4-beta-2 ligands and methods therefor
US9029557B2 (en) 2004-12-07 2015-05-12 The Regents Of The University Of California Labeled A4B2 ligands and methods therefor
US8316104B2 (en) 2005-11-15 2012-11-20 California Institute Of Technology Method and apparatus for collaborative system
AU2006331790A1 (en) * 2005-12-19 2007-07-05 Comentis, Inc. Topical mecamylamine formulations for ocular administration and uses therof
BRPI0621650A2 (pt) * 2006-05-08 2011-12-20 Arturo Solis Herrera composições farmacêuticas que induzem a liberação do alfa-msh endogênico a partir de células-tronco, e usos de uma substáncia ativa que induz a referida liberação e de alfa-msh sintetizado por qualquer meio
CA2794097C (en) * 2010-03-23 2016-08-09 Rock Creek Pharmaceuticals, Inc. Use of anatabine to treat inflammation and methods of synthesizing anatabine
US8207346B2 (en) 2010-03-23 2012-06-26 Rock Creek Pharmaceuticals, Inc. Methods of synthesizing anatabine
AU2012302257A1 (en) 2011-08-29 2014-03-13 Rcp Development, Inc. Products for anti-inflammation support
CA2944226C (en) 2014-04-03 2021-03-02 Universite Laval Method for use of homopiperazinium compounds in the treatment of cancer
RU2593585C1 (ru) * 2015-06-26 2016-08-10 Общество с ограниченной ответственностью "Ритек-Фарма" Способ лечения табакокурения и других форм никотиновой зависимости, а также профилактики рецидивов табакокурения
CN113992687B (zh) * 2021-12-28 2022-04-08 浙江宇视科技有限公司 智能业务集群调度方法、装置、电子设备及存储介质

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2594296A (en) * 1948-06-24 1952-04-29 Aerosol Corp Lobeline aerosol dilating medicament
US2778772A (en) 1952-11-04 1957-01-22 Parke Davis & Co Dimethyl phenyl piperazinium iodide compositions and process for stimulation of the autonomic ganglion system
US3402039A (en) 1966-12-05 1968-09-17 Dow Chemical Co Piperazinium salts as plant stunting agents
US5977144A (en) 1992-08-31 1999-11-02 University Of Florida Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
EP0791584A4 (en) * 1994-11-11 1997-11-19 Nippon Soda Co OPTICALLY ACTIVE CONNECTIONS
US5846983A (en) * 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
RU2127123C1 (ru) 1996-06-04 1999-03-10 Московское производственное химико-фармацевтическое объединение им.Н.А.Семашко Противоастматическое лекарственное средство в виде таблеток и способ получения таблеток
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
US5981549A (en) 1997-02-14 1999-11-09 Synapse Pharmaceutical International Method for controlling or alleviating the symptoms of respiratory disease and allergies
HU226859B1 (en) 1997-10-27 2009-12-28 Neurosearch As Phenyl- or heteroaryl-homopiperazines, their use and medicaments containing them
EP1434573A2 (en) 1998-10-20 2004-07-07 Omeros Corporation Irrigation solution and method for inhibition of pain and inflammation
DE60045240D1 (de) * 1999-03-02 2010-12-30 Centocor Inc Antikörper gegen tnf alpha zur therapie von steroidresistentem asthma
WO2000078319A1 (en) 1999-06-21 2000-12-28 Bristol-Myers Squibb Company Dihydropyrazine derivatives as npy antagonists
SE0001075D0 (sv) 1999-09-01 2000-03-27 Laszlo Bense Användning av åtminstone ett nikotinbaserat ämne och/eller ett ur detta ämne framställt ämne för tillverkning av ett medikament samt förfarande för behandling av obstruktiva lungsjukdomar
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
US6610713B2 (en) 2000-05-23 2003-08-26 North Shore - Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
WO2002044176A1 (en) 2000-12-01 2002-06-06 Neurosearch A/S 3-substituted quinuclidines and their use as nicotinic agonists
US20020160988A1 (en) 2001-02-20 2002-10-31 Israel Institute For Biological Research Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
BR0208303A (pt) 2001-03-22 2004-03-09 Battelle Memorial Institute Formações liquidas para pulverização eletroidrodin mica contendo polìmero e partìculas suspensas
US20050130990A1 (en) 2001-03-23 2005-06-16 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
CA2341952A1 (en) 2001-03-23 2002-09-23 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
GB2381750A (en) 2001-10-10 2003-05-14 Inspire Pharmaceuticals Inc Treatment for enhancing joint lubrication
US20030236287A1 (en) 2002-05-03 2003-12-25 Piotrowski David W. Positive allosteric modulators of the nicotinic acetylcholine receptor
TW200412945A (en) 2002-10-25 2004-08-01 Upjohn Co Quaternary ammonium compounds
EP1558563A1 (en) 2002-10-29 2005-08-03 Pharmacia & Upjohn Company LLC Quaternary ammonium compounds
EP1562599A1 (en) 2002-10-29 2005-08-17 Pharmacia & Upjohn Company LLC Quaternary ammonium compounds as muscarinic receptor antagonists
US20050075323A1 (en) 2003-03-05 2005-04-07 Pfizer Inc Beta3 adrenergic receptor agonists and uses thereof
FR2852830B1 (fr) 2003-03-24 2008-04-18 Oreal Composition de teinture des fibres keratiniques comprenant un derive de para-phenylenediamine cationique substitue par un cycle diazacyclohexane ou diazacycloheptane
JP2006523676A (ja) 2003-04-15 2006-10-19 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 第四級アンモニウム化合物と、その抗ムスカリン性剤としての使用
ES2445751T3 (es) 2004-07-15 2014-03-05 UNIVERSITé LAVAL Agonistas de receptor nicotínico para el tratamiento de enfermedades inflamatorias

Also Published As

Publication number Publication date
EP1370264A2 (en) 2003-12-17
MXPA03008423A (es) 2004-03-19
NO20034185D0 (no) 2003-09-19
RU2003131178A (ru) 2005-04-10
DE60223508T2 (de) 2008-09-25
JP4377586B2 (ja) 2009-12-02
EP1370264B1 (en) 2007-11-14
WO2002076434A2 (en) 2002-10-03
CA2341952A1 (en) 2002-09-23
BR0208305A (pt) 2004-03-09
CN1498108A (zh) 2004-05-19
PL207880B1 (pl) 2011-02-28
RU2299731C2 (ru) 2007-05-27
WO2002076434A3 (en) 2003-07-17
CN100528159C (zh) 2009-08-19
ES2295331T3 (es) 2008-04-16
PL365224A1 (pl) 2004-12-27
ATE378051T1 (de) 2007-11-15
DE60223508D1 (de) 2007-12-27
US20110245270A1 (en) 2011-10-06
JP2004523588A (ja) 2004-08-05
US20040132737A1 (en) 2004-07-08
NO331674B1 (no) 2012-02-20
NO20034185L (no) 2003-11-24
US7601720B2 (en) 2009-10-13
US8377936B2 (en) 2013-02-19
US20100227871A1 (en) 2010-09-09
AU2002249023B2 (en) 2006-02-02
IL157757A0 (en) 2004-03-28
NZ528042A (en) 2005-10-28

Similar Documents

Publication Publication Date Title
DK1370264T3 (da) Nikotinreceptor-agonister til behndling af lungeinflammationssygdomme
DE60120936D1 (de) Behandlung von atemerkrankungen
NO20072466L (no) Fremgangsmate for a forhindre og behandle strukturendring i luftveier og pulmonal inflammasjon ved a anvende A2B-adenosinreseptorantagonister
NO20076561L (no) Imidazoquinoliner som lipid kinaseinhibitorer
CY1107498T1 (el) Φαρμακευτικη συνθεση πepιλαμβανουσα ρεσβepατρολη για την αγωγη φλεγμονωδων αναπνευστικων διαταραχων
TW200738729A (en) Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
WO2005000298A3 (en) 5-membered heterocycle-based p-38 inhibitors
NO20060978L (no) Farmasoytiske blandingr for behandling av prematur ejakulasjon ved pulmonal inhalering
MX344787B (es) Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara.
NO20074084L (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikamenter og medikamenter inneholdende disse
BR112021023054A2 (pt) Formas cristalinas de um inibidor de btk
BR0313718A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto
JOP20200314A1 (ar) تركيبات صيدلانية مستقرة لأجهزة إستنشاق جرعات مضغوطة معايرة الجرعة
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
WO2004056310A3 (en) Methods of diagnosis and treatment of interstitial lung disease
WO2017178897A3 (en) Compositions and methods for treating paranasal mucosa diseases with nicotinic acetylcholine receptor agonists
MX2023005801A (es) Derivados de ftalazina como inhibidores de purinoceptor 3 de p2x (p2x3).
MX2021014116A (es) Derivados de piridopirimidinas como inhibidores del purinoreceptor 3 de p2x (p2x3).
CA2441096A1 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases
NO20083508L (no) Nye enantiomerisk rene beta-agonister, deres fremstillingsmate og deres anvendelse som medikamenter
MA28930B1 (fr) Derives pyridiniques d'indolin-2-one , leur preparation et leur application en therapeutique
MX2021003668A (es) Composición de ketamina para su uso en un método de tratamiento de la depresión por administración pulmonar.
WO2004103295A3 (en) Interleukin-9 antagonist muteins and their pharmacological methods of use
Sharma et al. In Vivo Effectiveness Of Bitter Taste Receptor Agonists In Mouse Models Of Allergic Asthma
UA102970C2 (ru) Противотуберкулезное лечебное средство на основе 4-тиоуреидоиминометилпиридиния перхлората, способ его полученя и способ лечения